4-boronophenylalanine has been researched along with Local Neoplasm Recurrence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kumada, H; Matsuda, M; Matsumura, A; Nakai, K; Shirakawa, M; Tsurubuchi, T; Yamamoto, T | 1 |
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Ariyoshi, Y; Kawabata, S; Kimura, Y; Maruhashi, A; Miyatake, S; Ono, K; Shimahara, M; Suzuki, M | 1 |
3 other study(ies) available for 4-boronophenylalanine and Local Neoplasm Recurrence
Article | Year |
---|---|
Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Topics: Adult; Aged; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Phenylalanine; Photons; Radiotherapy Dosage; Retrospective Studies; Sulfhydryl Compounds; Survival Rate; Treatment Failure | 2009 |
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution | 2009 |
Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.
Topics: Adult; Aged; Aged, 80 and over; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Pain; Phenylalanine; Positron-Emission Tomography; Quality of Life; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |